DE3586304D1 - Verfahren zur herstellung von proteinen und transformierten zellen und dna-konstruktionen zur korrektur von mankos und wirtszellen sowie deren herstellung und verwendung. - Google Patents
Verfahren zur herstellung von proteinen und transformierten zellen und dna-konstruktionen zur korrektur von mankos und wirtszellen sowie deren herstellung und verwendung.Info
- Publication number
- DE3586304D1 DE3586304D1 DE8585303702T DE3586304T DE3586304D1 DE 3586304 D1 DE3586304 D1 DE 3586304D1 DE 8585303702 T DE8585303702 T DE 8585303702T DE 3586304 T DE3586304 T DE 3586304T DE 3586304 D1 DE3586304 D1 DE 3586304D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- cells
- mancoses
- proteins
- correction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
- C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61473484A | 1984-05-25 | 1984-05-25 | |
US614734 | 1984-05-25 | ||
US73411985A | 1985-05-15 | 1985-05-15 | |
US734119 | 1985-05-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
DE3586304D1 true DE3586304D1 (de) | 1992-08-13 |
DE3586304T2 DE3586304T2 (de) | 1992-12-10 |
DE3586304T3 DE3586304T3 (de) | 2005-02-17 |
Family
ID=27087316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3586304T Expired - Lifetime DE3586304T3 (de) | 1984-05-25 | 1985-05-24 | Verfahren zur Herstellung von Proteinen und transformierten Zellen und DNA-Konstruktionen zur Korrektur von Mankos und Wirtszellen sowie deren Herstellung und Verwendung. |
Country Status (8)
Country | Link |
---|---|
US (2) | US5527668A (de) |
EP (1) | EP0171142B2 (de) |
JP (2) | JP2543497B2 (de) |
AT (1) | ATE78055T1 (de) |
AU (1) | AU600885B2 (de) |
CA (1) | CA1285505C (de) |
DE (1) | DE3586304T3 (de) |
DK (1) | DK175105B1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723292A (en) * | 1984-05-25 | 1998-03-03 | Zymogenetics, Inc. | Stable DNA constructs |
AU600885B2 (en) * | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
US4801542A (en) * | 1984-10-12 | 1989-01-31 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
EP0487116B1 (de) * | 1984-10-12 | 1999-12-29 | ZymoGenetics, Inc. | Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen |
DK594084A (da) * | 1984-12-12 | 1986-06-13 | Novo Industri As | Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning |
US4935349A (en) * | 1986-01-17 | 1990-06-19 | Zymogenetics, Inc. | Expression of higher eucaryotic genes in aspergillus |
EP0251579A3 (de) * | 1986-06-24 | 1989-03-22 | Enterovax Research Pty. Ltd. | Markiersystem ohne Antibiotika |
DE3751632T2 (de) * | 1986-08-13 | 1996-06-13 | Zymogenetics Inc | Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen |
US5474982A (en) * | 1986-08-13 | 1995-12-12 | Zymogenetics, Inc. | PDGF analogs and methods of use |
ATE103333T1 (de) * | 1987-03-23 | 1994-04-15 | Zymogenetics Inc | Hohe proteinsyntheserate in hefe. |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
US5135854A (en) * | 1987-10-29 | 1992-08-04 | Zymogenetics, Inc. | Methods of regulating protein glycosylation |
WO1989006694A1 (en) * | 1988-01-15 | 1989-07-27 | Trustees Of The University Of Pennsylvania | Process for selection of proteinaceous substances which mimic growth-inducing molecules |
US6004776A (en) * | 1989-07-07 | 1999-12-21 | Unilever Patent Holdings, B.V. | Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
EP0778348B1 (de) * | 1989-07-07 | 2000-09-20 | Unilever N.V. | Verfahren zur Herstellung eines Proteins mittels eines durch Mehrfachkopie-Integrierung eines Expressionsvektors tranformierten Pilzes |
US5759833A (en) * | 1994-05-27 | 1998-06-02 | Cubist Pharmaceuticals, Inc. | Human isoleucyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same |
GB2318732A (en) | 1996-11-01 | 1998-05-06 | Johnson & Johnson Medical | Wound healing compositions containing alpha-1-antitrypsin |
US20020119579A1 (en) * | 1998-07-14 | 2002-08-29 | Peter Wagner | Arrays devices and methods of use thereof |
US6897073B2 (en) * | 1998-07-14 | 2005-05-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
DE60044728D1 (de) | 1999-12-29 | 2010-09-02 | Novo Nordisk As | VERFAHREN ZUR HERSTELLUNG VON INSULINVORLäUFERN UND ANALOGEN VON INSULINVORLÄUFERN MIT VERBESSERTER FERMENTATIONSAUSBEUTE IN HEFE |
US7009045B2 (en) * | 2000-07-14 | 2006-03-07 | Archer-Daniels-Midland Company | Transformation systems for flavinogenic yeast |
EP1404713A4 (de) | 2001-05-24 | 2004-09-22 | Human Dna Technology Inc | Neues keratinocyte growth factor 2 analogon in haarfollikeln |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
ES2442615T5 (es) | 2002-07-18 | 2023-03-16 | Merus Nv | Producción recombinante de mezclas de anticuerpos |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
EP1639009B1 (de) | 2003-05-30 | 2013-02-27 | Merus B.V. | Fab-bibliothek zur herstellung von einer mischung von antikörpern |
JP2007532096A (ja) | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
ES2369895T3 (es) | 2003-12-03 | 2011-12-07 | Novo Nordisk A/S | Insulina monocatenaria. |
JP2006067883A (ja) * | 2004-09-01 | 2006-03-16 | Kao Corp | 組換えバチルス属細菌 |
IL165484A0 (en) * | 2004-11-30 | 2006-01-15 | Applied Research Systems | Production of proteins |
EP1831375B1 (de) * | 2004-12-23 | 2014-07-16 | Novozymes Biopharma DK A/S | Genexpressionsmethode |
CN102660614A (zh) | 2005-08-16 | 2012-09-12 | 诺沃-诺迪斯克有限公司 | 制备成熟胰岛素多肽的方法 |
ATE482977T1 (de) | 2006-02-27 | 2010-10-15 | Novo Nordisk As | Insulinderivate |
EP2046826B1 (de) | 2006-07-24 | 2011-09-14 | Biorexis Pharmaceutical Corporation | Exendin-fusionsproteine |
EP2069502B1 (de) | 2006-09-27 | 2014-02-26 | Novo Nordisk A/S | Verfahren zur herstellung gereifter insulinpolypeptide |
EP2114999A2 (de) | 2006-12-12 | 2009-11-11 | Biorexis Pharmaceutical Corporation | Transferrin-fusionsproteinbibliotheken |
WO2009021955A1 (en) | 2007-08-13 | 2009-02-19 | Novo Nordisk A/S | Rapid acting insulin analogues |
EP2178912B1 (de) | 2007-08-15 | 2015-07-08 | Novo Nordisk A/S | Insulinanaloge mit acyl- und alkylenglycolteilen |
ES2526924T3 (es) | 2007-08-15 | 2015-01-16 | Novo Nordisk A/S | Insulinas con una fracción acilo que comprende unidades repetitivas de aminoácidos que contienen alquilenglicol |
EP2504355B1 (de) | 2009-11-25 | 2015-07-22 | Novo Nordisk A/S | Verfahren zur herstellung von polypeptiden |
ES2543634T3 (es) | 2010-01-22 | 2015-08-20 | Novo Nordisk A/S | Proceso para preparación de FGF-21 con grado de O-glicosilación bajo |
NZ630551A (en) | 2012-04-20 | 2017-11-24 | Merus Nv | Methods and means for the production of ig-like molecules |
EP3004156A1 (de) | 2013-06-07 | 2016-04-13 | Novo Nordisk A/S | Verfahren zur herstellung von reifen insulinpolypeptiden |
KR102277898B1 (ko) * | 2014-07-03 | 2021-07-15 | 삼성전자주식회사 | 산물 생산능이 향상된 효모 및 그를 이용한 산물을 생산하는 방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
JPS55156591A (en) * | 1979-05-23 | 1980-12-05 | Ajinomoto Co Inc | Method for stabilizing property of bacteria containing plasmid |
JPS6048322B2 (ja) * | 1980-08-25 | 1985-10-26 | 松下電工株式会社 | セメント系無機材料の押出成形方法 |
US4506013A (en) * | 1980-10-03 | 1985-03-19 | Eli Lilly And Company | Stabilizing and selecting recombinant DNA host cells |
EP0076037B1 (de) * | 1981-09-02 | 1988-12-07 | Biogen, Inc. | Verstärkte Expression von DNS-Sequenzen |
CA1198069A (en) * | 1982-06-08 | 1985-12-17 | David H. Gelfand | Temperature sensitive multicopy plasmids |
GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
CA1209501A (en) * | 1982-09-16 | 1986-08-12 | Nikos Panayotatos | Expression vector |
GB8407498D0 (en) * | 1984-03-22 | 1984-05-02 | Biogen Nv | High copy number expression vectors |
AU600885B2 (en) * | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
US4931373A (en) * | 1984-05-25 | 1990-06-05 | Zymogenetics, Inc. | Stable DNA constructs for expression of α-1 antitrypsin |
-
1985
- 1985-05-23 AU AU42794/85A patent/AU600885B2/en not_active Ceased
- 1985-05-24 AT AT85303702T patent/ATE78055T1/de not_active IP Right Cessation
- 1985-05-24 DE DE3586304T patent/DE3586304T3/de not_active Expired - Lifetime
- 1985-05-24 CA CA000482272A patent/CA1285505C/en not_active Expired - Fee Related
- 1985-05-24 JP JP60111975A patent/JP2543497B2/ja not_active Expired - Lifetime
- 1985-05-24 EP EP85303702A patent/EP0171142B2/de not_active Expired - Lifetime
- 1985-05-24 DK DK198502350A patent/DK175105B1/da not_active IP Right Cessation
-
1993
- 1993-10-12 US US08/134,480 patent/US5527668A/en not_active Expired - Fee Related
-
1994
- 1994-05-31 JP JP6118650A patent/JP2704115B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/473,012 patent/US5700643A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3586304T2 (de) | 1992-12-10 |
EP0171142A1 (de) | 1986-02-12 |
DK235085A (da) | 1985-11-26 |
EP0171142B1 (de) | 1992-07-08 |
JP2543497B2 (ja) | 1996-10-16 |
EP0171142B2 (de) | 2004-09-01 |
US5700643A (en) | 1997-12-23 |
DE3586304T3 (de) | 2005-02-17 |
US5527668A (en) | 1996-06-18 |
JP2704115B2 (ja) | 1998-01-26 |
AU4279485A (en) | 1985-11-28 |
DK235085D0 (da) | 1985-05-24 |
JPH0767685A (ja) | 1995-03-14 |
AU600885B2 (en) | 1990-08-30 |
ATE78055T1 (de) | 1992-07-15 |
DK175105B1 (da) | 2004-06-01 |
CA1285505C (en) | 1991-07-02 |
JPS6156092A (ja) | 1986-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3586304T2 (de) | Verfahren zur herstellung von proteinen und transformierten zellen und dna-konstruktionen zur korrektur von mankos und wirtszellen sowie deren herstellung und verwendung. | |
ATE77104T1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
DE3851289D1 (de) | Verfahren zur Züchtung rekombinanter Zellen. | |
DE3888561D1 (de) | Hohe Proteinsyntheserate in Hefe. | |
BR8200191A (pt) | Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene | |
DE68926892D1 (de) | Verfahren zur Herstellung von Zellen, die stabil integrierte fremde DNS mit hoher Kopiezahl enthalten, durch dieses Verfahren hergestellte Zellen und Verwendung dieser Zellen zur Herstellung von durch diese fremde DNS kodierten Polypeptiden | |
DE69939947D1 (de) | Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen | |
DE69935978D1 (de) | Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung | |
DE69636899D1 (de) | Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion | |
DK237985A (da) | Genteknologisk fremgangsmaade til fremstilling af human-interleukin-2 og middel til gennemfoerelse af fremgangsmaaden | |
DE59108128D1 (de) | Verfahren zur Herstellung von Fremdproteinen in Streptomyceten | |
DE3484216D1 (de) | Biosynthetische 2,5-diketogluconsaeurereduktase, verfahren, rekombinante zellen und expressionsvektoren fuer ihre herstellung und ihre verwendung zur bereitung von 2-keto-l-gulonsaeure. | |
ATE451469T1 (de) | In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten | |
IE881779L (en) | Dna fragments, containing a lactic acid bacterium-specific¹regulator region for the expression of genes coding for¹normally heterologous proteins, recombinant plasmids based¹on such dna fragments, lactic acid bacteria which contain¹these recombinant plasmids and the heterologous proteins and¹products prepared with the aid of the above microorganisms | |
ATE266733T1 (de) | Verfahren zur herstellung von heterologen polypeptiden in transformierten hefezellen | |
DE58909205D1 (de) | Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten. | |
AU6433886A (en) | A method for the expression of genes in yeast, and DNA fragments as well as plasmids comprising said DNA fragments to be used when carrying out the method | |
ATE44767T1 (de) | Positives retroregulatorisches element, plasmid und zellen die dieses element enthalten und deren herstellung, verfahren zur steigerung der genexpression unter verwendung des genannten elements und verfahren zur steigerung der halbwertzeit der rna unter verwendung des genannten elements. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |